ArticleCancer gene therapy2022

Reovirus mutant jin-3 exhibits lytic and immune-stimulatory effects in preclinical human prostate cancer models.

Arjanneke F van de Merbel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.